References Kapoor R, Shome D, Vadera S, Kumar V, Ram MS
While Semaglutide offers significant benefits for managing diabetes and weight loss, it may also lead to gastrointestinal issues such as nausea, vomiting, and diarrhea
Since then, the mechanisms and benefits of GLP-1s have become better understood and revealed new opportunities where they could potentially be used in the treatment of additional conditions
Several firms that initially covered GLP-1 drugs for weight loss have since restricted coverage to only cover GLP-1 agonists for employees with specific medical indications, like diabetes
Second, although the conjugation of the toxic intermediate NAPQI by glutathione is an important protective mechanism, it occurs after the production of NAPQI, while glucoronidation removes APAP before the production of NAPQI